In the surgical literature, the risk of incidental findings, or incidentalomas, with medical imaging is well documented. 9, 10 Up to 40 percent of trauma patients receiving a routine spiral computed tomographic scan will show incidental findings. 11 Within the plastic surgery literature, one study has reported on incidental findings, noting a 13 percent rate on abdominal/pelvic computed tomographic imaging in preparation for abdominally based perforator breast reconstruction. 12 However, this study did not report on the cost associated with these incidental findings and also omitted chest computed tomographic angiography, which may be occasionally ordered and potentially adds to the risk for incidental findings. Incidental findings may introduce alterations to the intended surgical plan or warrant further follow-up. The latter increases the cost of patient care and may add to patient anxiety in anticipation of further evaluation. 13, 14 Furthermore, these incidental findings may lead to unplanned invasive procedures often required for final pathologic evaluation. 15 Given increasingly restrictive health care cost measures and because of the growing use of preoperative computed tomographic angiography in preparation for breast reconstruction, there is a need to understand the economic cost associated with this imaging modality. We hypothesized that the workup for incidental findings would add significant cost because of evaluation of incidental findings in addition to the actual cost of computed tomographic angiography. In this study, we present our experience with incidental findings in patients with preoperative computed tomographic angiography before autologous breast reconstruction and the costs associated with these incidental findings.
PATIENTS AND METHODS
This retrospective chart review was approved by the University of Michigan Institutional Review Board. Only patients who underwent preoperative computed tomographic angiography in preparation for autologous abdominally based breast reconstruction from July 8, 2010, to May 22, 2014 , were included in this study. Patients who underwent computed tomographic angiography for evaluation of the thoracodorsal pedicle in preparation for a latissimus dorsi muscle flap were excluded. All patients scanned in preparation for abdominally based autologous reconstruction were included; this included patients who initially desired autologous breast reconstruction but subsequently decided to undergo implant reconstruction. The medical record was reviewed for both demographic and clinical data points, including the need for further medical imaging, diagnostic laboratory testing, or invasive procedures associated with their preoperative computed tomographic angiography findings, and the final diagnosis associated with any incidental findings. The impact of incidental findings on final reconstruction status was also determined.
Identification of Incidental Findings
An incidental finding was defined as any new finding made on imaging that was otherwise unexpected and unrelated to the original purpose for imaging. Evidence of similar findings on previous imaging in the same patient was not considered an incidental finding. In our selected cohort of patients, the original purpose for imaging was evaluation of the vascular anatomy of the abdominal soft tissue in preparation for autologous breast reconstruction. Incidental findings were then determined to have clinical significance if additional follow-up was recommended by the radiologist.
Cost Determination
The cost associated with computed tomographic angiography and follow-up imaging or invasive procedures associated with incidental findings was determined using the 2015 Healthcare Bluebook, which cites "fair prices" that a cash-paying patient pays. For patients with documented follow-up at our institution, we were able to calculate the cost for additional imaging and/ or invasive procedures. For those patients who opted to have follow-up outside our institution, we included only the cost of any initial follow-up recommended by the radiologists at our institution. The Healthcare Bluebook has previously been used as a method of estimating costs associated with laboratory studies and procedures. [16] [17] [18] By using the same table of costs for the entire study cohort, we are able to use current day values while obviating Consumer Price Index adjustments.
RESULTS
A total of 135 patients underwent preoperative computed tomographic angiography in preparation for autologous abdominally based breast reconstruction. Of these, 127 patients (94 percent) went on to have autologous breast reconstruction, one patient underwent implantbased reconstruction, and seven patients did not undergo reconstruction at our institution.
Incidental findings requiring follow-up were noted on the radiologist's final computed tomography read in 21 percent (28 of 135) of patients (Table 1) . Of these 28 patients, 16 (57 percent) were noted to have undergone further testing, including chest computed tomography, abdominal ultrasound, abdominal magnetic resonance imaging, pelvis magnetic resonance imaging, positron emission tomography, neck ultrasound, colonoscopy, or ultrasound-guided biopsy at our institution ( Table 2) . One patient required an additional surgical procedure for resection of a benign gastric mass, which was found to be a gastric schwannoma on final pathologic evaluation. Another patient required a thyroidectomy for a substernal goiter, which was determined to be a benign multinodular goiter on final pathologic evaluation. Twelve patients did not have further testing documented at our institution, although this did not preclude testing that took place at outside institutions. In our cohort, no patients were noted to have evidence of local recurrence or distant metastatic breast cancer.
We next stratified incidental findings based on the anatomical site of imaging: computed tomographic scan of the abdomen/pelvis versus the chest/abdomen/pelvis. This distinction was made because of our observation that lung nodules, which may be incidental findings, may increase the cost associated with computed tomographic angiography when chest is included. In our series, we found that 47 percent (63 of 135) of patients underwent computed tomographic angiography of the abdomen/pelvis, whereas the remaining 53 percent (72 of 135) underwent computed tomographic angiography of the chest/abdomen/pelvis. Of those patients who underwent computed tomographic angiography of the abdomen/pelvis, 8 percent (five of 63) had incidental findings and 32 percent (23 of 72) of patients with computed tomographic angiography of the chest/abdomen/ pelvis had incidental findings (Table 3) . Of the 23 patients with positive findings on computed tomographic angiography of the chest/abdomen/ pelvis, 17 patients (74 percent) had positive findings on the chest portion of imaging. Five patients (22 percent) who had computed tomography of the chest/abdomen/pelvis had incidental findings on the abdomen/pelvis portion only and one patient had positive findings on both the chest and abdomen/pelvis portion of imaging.
Costs associated with imaging and additional testing or intervention was determined based on the Healthcare Bluebook ( Table 1 ). The mean cost per patient directly associated with computed tomographic angiography of our cohort in preparation for free-flap reconstruction was $1267 per patient. Among those patients with incidental findings and known follow-up, the mean cost for additional workup was $2777 per patient. Among those patients with incidental findings without known evaluation of these findings, the mean cost for additional workup associated with radiologist recommendations was $902 per patient; this cost does not include any additional workup that may be required beyond the radiologist's initial recommendations. Averaged over the entire cohort, the mean cost associated with an incidental finding was $409 per patient. Combining the cost of both the computed tomographic angiography and the workup for incidental findings results in a mean cost per patient of $1677, representing a 32 percent increase to the cost of computed tomographic angiography alone. If all patients had undergone imaging restricted to the abdomen/pelvis instead of chest/ abdomen/pelvis, the mean cost per patient for imaging alone would have been $927 per patient. Eleven patients in the cohort had incidental findings on computed tomographic angiography of the abdomen/pelvis; therefore, if computed tomographic angiography of the abdomen/pelvis had been ordered only, the total cost associated with additional workup would have been $174 per patient when averaged over the entire 135-patient cohort (total cost, $23,427). The mean per-patient cost would have been $1101, including cost for computed tomographic angiography imaging, resulting in an increase of 19 percent over the cost of the initial computed tomographic angiography.
DISCUSSION
In this study, we report on our institution's experience with routine preoperative computed tomographic angiography in preparation for autologous breast reconstruction. We found that were not evaluated at our institution, the cost of the baseline computed tomographic angiography was $1512 per patient and the cost of incidental findings was $902 per patient. However, it should be noted that in those patients without documented follow-up, costs for incidental findings were determined based on the radiologist's initial recommendations and do not account for any other testing that may have been required on execution of these recommendations. We believe this explains the differences in total cost per patient between these two cohorts seen in Table 1 . These economic costs do not take into account the anxiety associated with additional testing/invasive procedures required for patients with incidental findings. The vast majority of incidental findings in our series were managed with additional imaging and did not effectively alter the course of care for our patients. However, we did note two patients requiring additional invasive procedures attributable to findings identified on computed tomographic angiography. In our series, one patient was diagnosed with a gastric schwannoma. This is an exceedingly rare diagnosis, and the literature suggests that this is a benign tumor that poses minimal risk of malignancy. However, because of the difficulty in differentiating schwannoma from the malignant gastrointestinal stromal tumor, tissue diagnosis is required, thereby necessitating a biopsy. 19, 20 In the absence of computed tomographic angiography, this patient likely would not have undergone this invasive procedure. The other patient underwent a thyroidectomy for an ultimately benign goiter noted because of chest computed tomographic angiography. In our institutional review board-defined cohort, we did not have any patients with computed tomographic angiography findings concerning for recurrent breast cancer. However, we subsequently have had one patient diagnosed with metastatic breast cancer found on her preoperative computed tomographic angiography image obtained outside of the defined study period. It is important to note that computed tomographic imaging is not indicated in the surveillance imaging of patients with a history of breast cancer based on guidelines from the American Society of Clinical Oncology. 21 During our analysis, we noted that some of the incidental findings were noted on chest computed tomographic angiography. Chest computed tomographic angiographs were obtained to evaluate internal mammary artery and thoracodorsal artery patency as recipient vessels and were more common in the earlier portion of our study. The impact of incidental findings related to chest computed tomographic angiography is notable given that over half of the patients in our cohort underwent chest computed tomographic angiography in addition to computed tomographic angiography of the abdomen/pelvis. The incidental findings noted with chest computed tomographic angiography have been primarily thyroid or lung nodules, and warrant further imaging to monitor evidence of changes in appearance. In addition, patients may experience anxiety related to the uncertainty of these incidental findings. More recently, we have decreased the use of chest computed tomographic angiography from our protocol, noting that in addition to the risk of incidental findings, this piece of imaging was less informative with respect to operative planning. In our experience, the major benefit of computed tomographic angiography appears to be for flap harvest, which is facilitated by abdomen/pelvis imaging. If a computed tomographic scan of the abdomen/pelvis had been obtained for all patients in our cohort instead of a computed tomographic scan of the chest/abdomen/pelvis, the mean cost per patient for imaging alone would have been $927, instead of $1267 per patient. In addition, the mean cost of incidental findings would have been $174 per patient instead of $409 per patient. Therefore, ordering computed tomographic angiography of the abdomen/pelvis only would have reduced the cost associated with incidental findings.
Computed tomographic angiography has previously been shown to significantly reduce the odds of partial necrosis and total flap loss when compared to Doppler ultrasonography. 1 Additional reports have indicated that computed tomographic angiography can decrease operative time by over 1 hour, in addition to decreasing intraoperative blood loss. 22 However, one other study found 809e a mean decrease of only 6 minutes' operative time. 8 It is likely that the utility of computed tomographic angiography is dependent on the operative experience of the surgeon. Offodile et al. have performed a cost-utility analysis of computed tomographic angiography versus Doppler imaging for preoperative planning and noted that, even when assuming operative time is not decreased, computed tomographic angiography remains cost-effective; importantly, however, this analysis did not take into consideration the costs associated with incidental findings on computed tomographic angiography. 23 Our results suggest that the estimated cost of computed tomographic angiography may increase by as much as 30 percent when these costs are taken into consideration, although avoidance of chest imaging may mitigate this cost increase. We would encourage future studies examining the cost-effectiveness of preoperative computed tomographic angiography to include the costs of incidental findings in their analysis. This study has several limitations. First, this is a single-institution study with limited sample size. As a tertiary care center with a large referral population, it is possible that patients have had prior cross-sectional imaging at other institutions that would establish the long-term temporal stability of some of the incidentally discovered findings on computed tomographic angiography. If long-term temporal stability can be documented, a nonaggressive pathologic condition/cause is generally inferred, and this may preclude the need for additional imaging or workup. In addition, generalizability to other institutions is limited because of possible interinstitutional differences in radiology recommendations. Costs are often institutionspecific based on negotiated payments. In this study, we use the Healthcare Bluebook, as this is a publicly accessible information source that can be used to provide a uniform metric for cost. In addition, our rate of incidental findings is comparable to that in previously published reports. We are also unable to quantify the cost savings associated with time saved in the operating room associated with using abdominal computed tomographic angiography; however, the purpose of this study was to evaluate the true costs of computed tomographic angiography and assist with sensitivity analysis for those future studies focused on cost-effectiveness of computed tomographic angiography. Finally, we are unable to address indirect costs associated with computed tomographic angiography, including staff costs in coordination of care, radiation exposure, potential dye reaction, loss of time from work, transportation requirements for additional follow-up, the cost of delayed/cancelled reconstruction, or the psychological toll of "incidental" findings in patients with a history of breast cancer. We are also unable to address the potential costs associated with delays in reconstruction and operative resource use. Finally, our study examined the cost of computed tomographic angiography with respect to the global health care system. Ironically, the additional workup studies can actually be profitable to the individual hospital or provider; however, that is not the intention of this article, as our focus is on the overall costs of health care from a societal perspective.
CONCLUSIONS
In summary, our findings are important, as they provide additional quantification of the cost of computed tomographic angiography in the setting of autologous breast reconstruction. Importantly, our analysis takes into account the cost of incidental findings and identified an increase of 30 percent in the baseline cost of a computed tomographic angiography scan on a per-patient basis. However, our findings indicate that by performing computed tomographic angiography of the abdomen/pelvis and omitting chest imaging, the rate of incidental findings can be decreased by nearly 60 percent. This may substantially reduce the costs associated with incidental lung and thyroid findings, which often require additional imaging or intervention.
